Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

University of British Columbia

$9,993.00

Leveling the playing field: improved diagnosis and outcomes for young women with myocardial infarction

FY 2016-17

Summary
When a person with chest pain is admitted to the emergency room for a suspected heart attack, a blood test is conducted to measure levels of a protein called troponin in the blood. When a person has damage to their heart, as in the case with a heart attack, blood levels of troponin are increased significantly, confirming for doctors that a heart attack has occurred. A patient who is diagnosed as having a heart attack receives many tests and treatments to ensure optimal recovery once discharged from the hospital. A patient who is NOT appropriately diagnosed with a heart attack will not get additional tests, and may or may not be discharged with medications to help them recover. Research has shown that getting a proper diagnosis of heart attack is very important in determining a patient's future health and recovery. Currently, there is a single value for the troponin blood test that doctors use to determine whether a patient has had a heart attack or not. Patients with troponin levels above this value receive well-established treatments for their heart attack, and patients with troponin levels below this value do not. Recently, research has shown that the levels of troponin may differ between men and women, specifically that women have lower levels of troponin to begin with. This finding has an enormous impact on how women are diagnosed and treated. If a woman has lower levels of troponin after a heart attack, and does not reach the current threshold needed to receive a diagnosis of heart attack, she is put in a disadvantaged situation as she will not receive the proper treatment needed for recovery. With this grant, we hope to plan a large, nationwide study to evaluate whether having different troponin values for heart attack diagnosis in men and women will result in more women getting better treatments and recovery. The results can make a big difference in how women in Canada are diagnosed and how well they recover from a heart attack.
Program
Planning and Dissemination Grant - Institute Community Support
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
365752
Name
Humphries Karin H
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Clinical
Prcname2
Planning and Dissemination - IGH
Projecttitle
Leveling the playing field: improved diagnosis and outcomes for young women with myocardial infarction
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$9,993
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Diagnosis; High Sensitivity Cardiac Troponin; Myocardial Infarction; Randomized Control Trial; Sex Differences; Young Women
Abstract
When a person with chest pain is admitted to the emergency room for a suspected heart attack, a blood test is conducted to measure levels of a protein called troponin in the blood. When a person has damage to their heart, as in the case with a heart attack, blood levels of troponin are increased significantly, confirming for doctors that a heart attack has occurred. A patient who is diagnosed as having a heart attack receives many tests and treatments to ensure optimal recovery once discharged from the hospital. A patient who is NOT appropriately diagnosed with a heart attack will not get additional tests, and may or may not be discharged with medications to help them recover. Research has shown that getting a proper diagnosis of heart attack is very important in determining a patient's future health and recovery. Currently, there is a single value for the troponin blood test that doctors use to determine whether a patient has had a heart attack or not. Patients with troponin levels above this value receive well-established treatments for their heart attack, and patients with troponin levels below this value do not. Recently, research has shown that the levels of troponin may differ between men and women, specifically that women have lower levels of troponin to begin with. This finding has an enormous impact on how women are diagnosed and treated. If a woman has lower levels of troponin after a heart attack, and does not reach the current threshold needed to receive a diagnosis of heart attack, she is put in a disadvantaged situation as she will not receive the proper treatment needed for recovery. With this grant, we hope to plan a large, nationwide study to evaluate whether having different troponin values for heart attack diagnosis in men and women will result in more women getting better treatments and recovery. The results can make a big difference in how women in Canada are diagnosed and how well they recover from a heart attack.
Competitiondate
201702
Approvedterm2
1 yr 0 mth
Pinamesdelim
Humphries, Karin H; Christenson, James M; Kavsak, Peter A
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Gender & Health~ $9,993~ $0~